MAPT and Alzheimer disease: The strong putative protective effect of homozygous APOE3ch in this patient suggests that ApoE may be one of the main modulators of tau pathology in AD, possibly via different mechanisms including aggregation by modifying ApoE heparin binding [1], and homeostatic regulation of glial cells.